Frontiers in Immunology, 2022
Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection

Molinero M., Gómez S., Benítez I. et al.

Development, 2022
Coupled myovascular expansion directs cardiac growth and regeneration

DeBenedittis P., Karpurapu A., Henry A. et al.

British Journal of Cancer, 2022
Breast density is strongly associated with multiparametric magnetic resonance imaging biomarkers and pro-tumorigenic proteins in situ

Lundberg P., Forsgren M., Tellman J. et al.

Clinical and Experimental Immunology, 2022
Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response

Valli A., Kuuliala K., Virtanen A. et al.

Environmental Research, 2022
Ambient air pollution and inflammation-related proteins during early childhood

He S., Klevebro S., Baldanzi G. et al.

Clinical & Experimental Allergy, 2022
Exploring proteomic plasma biomarkers in eosinophilic and neutrophilic asthma

Kere M., Klevebro S., Hernandez‐Pacheco N. et al.

ESC Heart Failure, 2022
Elevated plasma WIF‐1 levels are associated with worse prognosis in heart failure with pulmonary hypertension

Kania K., Ahmed A., Ahmed S. et al.

Alzheimer's Research & Therapy, 2022
Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study

Trares, K., Bhardwaj et al.

Clinical Kidney Journal, 2022
The use of plasma biomarker-derived clusters for clinicopathologic phenotyping: results from the Boston Kidney Biopsy Cohort

Schmidt I., Myrick S., Liu J. et al.

Journal of Clinical Immunology, 2022
Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors

Borgström E., Edvinsson M., Pérez L. et al.

Neurology Neuroimmunology & Neuroinflammation, 2022
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis

Thonhoff J., Berry J., Macklin E. et al.

JACC: Heart Failure, 2022
Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure

Pandhi P., ter Maaten J., Anker S. et al.

European Heart Journal, 2022
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme

Zannad F., Ferreira J., Butler J. et al.

eBioMedicine, 2022
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma

Rossi N., Lee K., Bermudez M. et al.

Science Advances, 2022
Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods

Katz D., Robbins J., Deng S. et al.

Physiological Reports, 2022
Quantifying the inflammatory secretome of human intermuscular adipose tissue

Kahn D., Macias E., Zarini S. et al.

Scientific Reports, 2022
Association of extracellular vesicle inflammatory proteins and mortality

Noren Hooten N., Torres S., Mode N. et al.

Nature Communications, 2022
ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19

Pietzner M., Chua R., Wheeler E. et al.

Nordic Journal of Psychiatry, 2022
Intercorrelation of physiological seizure parameters and hormonal changes in electroconvulsive therapy

Thörnblom E., Gingnell M., Cunningham J. et al.

Multiple Sclerosis and Related Disorders, 2022
High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial

Englund S., Piehl F., Kierkegaard M.